Medical-device companies could benefit from an improving economy and a clearer view of health-system changes this year, but they will still have to contend with plenty of challenges.
These include toughening regulatory oversight, hospitals battling high device prices, an expected multibillion-dollar tax as part of health-overhaul legislation, and no big innovations to invigorate sales.
"I don't see [device companies] ever going back to the premiums they used to command, at least until there are some new technologies driving growth," said Tim Nelson, a senior health-care analyst at FAF Advisors Inc. in Minnesota, which owns shares of device companies.
Device stocks ...





: Great to share nice ideas. ------------ ...
: Great article! Excellent points made. Thanks!...
Drue De Angelis: The overarching theme from the halls of JP Morgan was that the capital...
Treating Scoliosis: Advances in scoliosis treatment have been monumental. Although, surge...
Diane Siriani: Interesting information! ...